ANGIOJECT

ANGIOJECT is an FDA 510(k)-cleared medical device (K860842) manufactured by Target Therapeutics. This device is classified under the Cardiovascular specialty. FDA Device Class II (Special Controls) — moderate risk, requires 510(k) clearance. FDA clearance granted on April 22, 1986. Regulation: 8.